What are mostOvervalued biotechnology stocks?
They are Biotechnology names trading above modeled intrinsic value—shown here as downside % versus price. Models vary; use this as a screen, not advice.
Search companies or stocks...
Top MostOvervalued Biotechnology industry Stocks 2026
Savara (SVRA) is the most overvalued stock in the Biotechnology industry with an estimated 99.7% downside, followed by Spyre Therapeutics, (SYRE) at 99.7%, Revolution Medicines, (RVMD) at 99.3%, and Centessa Pharmaceuticals (CNTA) at 98.8%.
Updated todayBased on intrinsic value modelsIndustry: Biotechnology
Page snapshot: 19 July 2026, 12:45 am
View full analysis in the screener → · All most overvalued stocks →
Before you trade on valuation alone
Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.
Biotechnology Industry Valuation Insights (Updated Today)
- The Biotechnology industry currently shows an average upside of 75.2% on this snapshot.
- Top name Savara Inc. (SVRA) trades at roughly a 99.7% discount to modeled intrinsic value—rankings move with prices and inputs.
- This industry's average upside is below our broad mostOvervalued benchmark (~95.3%).
MostOvervalued Biotechnology Stocks by Market Cap
Large cap (top 5)
- 1.Revolution Medicines, Inc. · RVMD99.3%$39.58B
- 2.Summit Therapeutics Inc. · SMMT98.1%$10.72B
- 3.Abivax S.A. · ABVX91.7%$10.03B
- 4.Roivant Sciences Ltd. · ROIV79.7%$24.82B
- 5.Genmab A/S · GMAB75.3%$17.63B
Mid cap (top 5)
- 1.Spyre Therapeutics, Inc. · SYRE99.7%$6.04B
- 2.Centessa Pharmaceuticals plc · CNTA98.8%$6.27B
- 3.Oruka Therapeutics, Inc. · ORKA98.8%$3.47B
- 4.Cogent Biosciences, Inc. · COGT97.7%$6.68B
- 5.Scholar Rock Holding Corporation · SRRK96.4%$6.33B
Small cap (top 5)
- 1.Savara Inc. · SVRA99.7%$1.13B
- 2.Wave Life Sciences Ltd. · WVE98.4%$1.12B
- 3.Tourmaline Bio, Inc. · TRML97.5%$1.23B
- 4.Amylyx Pharmaceuticals, Inc. · AMLX86.3%$1.48B
- 5.Zenas BioPharma, Inc. · ZBIO85.0%$1.32B
What Are the Most Overvalued Biotechnology Stocks?
Most overvalued biotechnology stocks are names where price sits furthest above modeled fair (intrinsic) value—often expressed as the largest headline downside versus price.
This is not a sell list. Validate each symbol on its company page before you act.
How We Identify the Most Overvalued Biotechnology Stocks
We pull an industry-filtered most-overvalued snapshot (price, intrinsic value, downside, cap, sector, country) and rank by headline downside. You can sort and search in the table above.
Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.
FAQs
Answers about the most overvalued biotechnology names, intrinsic value, and how often this list refreshes.
How do you find mostOvervalued biotechnology stocks?
We load mostOvervalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.
Why are biotechnology stocks mostOvervalued?
Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.
Are mostOvervalued biotechnology stocks a good investment?
Not by label alone. Discounts can reflect risk or data lag. Check fundamentals and your goals; seek professional advice if needed.
How often is this list updated?
The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.